As MIP-1β is a chemokine ligand for CCR5, it may act as an endogenous inhibitor of infection with M-tropic-HIV-1 strains and reduce disease progression (42, 43), contrarily prior to HIV-1 acquisition, higher levels of MIP-1β has been associated with increased susceptibility to HIV-1 acquisition (44). Here, CCL4 is linked to infection.